Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and other key speakers, will host a call to discuss recent UPNEEQ® trends, pending expansion into the medical Aesthetics market and other general business updates as follows:
Date: Wednesday, January 19, 2022
Time: 8:30 a.m. ET
Webcast: https://experience.v-unite.com/#/aestheticrecorddemo/rvlinvestorday/room/welcome

The webcast will be available thereafter via the Company’s website at www.rvlpharma.com under the “Investor & News” section.

About Osmotica Pharmaceuticals plcOsmotica Pharmaceuticals plc (Nasdaq: OSMT) is a specialty pharmaceutical company focused on the development and commercialization of products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc., is the Company’s ophthalmic and medical aesthetics subsidiary supporting UPNEEQ®.

Investor and Media Relations for Osmotica Pharmaceuticals plcLisa M. WilsonIn-Site Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com

Osmotica Pharmaceuticals (NASDAQ:OSMT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Osmotica Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Osmotica Pharmaceuticals (NASDAQ:OSMT)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Osmotica Pharmaceuticals 차트를 더 보려면 여기를 클릭.